TScan Therapeutics had a revenue of 0.00 in the quarter ending Jun 30, 2025, with -100.00%. This bring the company's revenue in the last twelve months to 3.88M, Increased -12.12%. In the fiscal year ending Dec 31, 2024, TScan Therapeutics had annual revenue of 2.82M with -86.62% growth.